"Leukemia, B-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease of the B-LYMPHOCYTES in the bone marrow and/or blood.
| Descriptor ID |
D015448
|
| MeSH Number(s) |
C04.557.337.428.080 C15.604.515.560.080 C20.683.515.528.080
|
| Concept/Terms |
Leukemia, B-Cell- Leukemia, B-Cell
- Leukemia, B Cell
- Lymphocytic Leukemia, B-Cell
- B-Cell Lymphocytic Leukemia
- B-Cell Lymphocytic Leukemias
- Leukemia, B-Cell Lymphocytic
- Leukemias, B-Cell Lymphocytic
- Lymphocytic Leukemia, B Cell
- Lymphocytic Leukemias, B-Cell
- Leukemia, Lymphocytic, B Cell
- Leukemia, Lymphocytic, B-Cell
- B-Cell Leukemia
- B Cell Leukemia
- B-Cell Leukemias
- Leukemias, B-Cell
- B-Lymphocytic Leukemia
- B Lymphocytic Leukemia
- B-Lymphocytic Leukemias
- Leukemia, B-Lymphocytic
- Leukemias, B-Lymphocytic
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, B-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, B-Cell".
This graph shows the total number of publications written about "Leukemia, B-Cell" by people in this website by year, and whether "Leukemia, B-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, B-Cell" by people in Profiles.
-
Andrews JM, Pyfrom SC, Schmidt JA, Koues OI, Kowalewski RA, Grams NR, Sun JJ, Berman LR, Duncavage EJ, Lee YS, Cashen AF, Oltz EM, Payton JE. Loss of synergistic transcriptional feedback loops drives diverse B-cell cancers. EBioMedicine. 2021 Sep; 71:103559.
-
Waldron T, De Dominici M, Soliera AR, Audia A, Iacobucci I, Lonetti A, Martinelli G, Zhang Y, Martinez R, Hyslop T, Bender TP, Calabretta B. c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia. 2012 Apr; 26(4):644-53.
-
Morisot S, Wayne AS, Bohana-Kashtan O, Kaplan IM, Gocke CD, Hildreth R, Stetler-Stevenson M, Walker RL, Davis S, Meltzer PS, Wheelan SJ, Brown P, Jones RJ, Shultz LD, Civin CI. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia. 2010 Nov; 24(11):1859-66.
-
Awan FT, Lapalombella R, Trotta R, Butchar JP, Yu B, Benson DM, Roda JM, Cheney C, Mo X, Lehman A, Jones J, Flynn J, Jarjoura D, Desjarlais JR, Tridandapani S, Caligiuri MA, Muthusamy N, Byrd JC. CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody. Blood. 2010 Feb 11; 115(6):1204-13.
-
Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell. 2006 Apr; 9(4):261-72.
-
Prakash O, Swamy OR, Peng X, Tang ZY, Li L, Larson JE, Cohen JC, Gill J, Farr G, Wang S, Samaniego F. Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis. Blood. 2005 May 15; 105(10):3987-94.
-
Hardy RR. Development of VH11+ B cells: a model for selection of B cells producing natural autoantibodies. Curr Dir Autoimmun. 2003; 6:196-211.
-
Harris DT, Jaso-Friedmann L, Evans DL. A novel target cell antigen involved in the NK-like lytic activity of antigen-specific cytotoxic T lymphocytes. Immunol Lett. 1993 Sep; 38(1):11-8.